Saskatoon Health Region Report issue

Academic/Hospital Phase 3 Phase 4
Founded: Saskatoon Canada
Status: Defunct (2017)

Organization Overview

First Clinical Trial
2005
NCT00229567
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2016

Timeline

NOW
  • Now

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Coronary Artery Disease (Phase 3)

Depression (Phase 4)

Depressive Disorder (Phase 4)

Depressive Disorder, Treatment-Resistant (Phase 4)

Drug-Related Side Effects and Adverse Reactions (Phase 4)

Postoperative Hemorrhage (Phase 3)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 6
  • # of Trial APIs: 8